Pharmas manufacturing national essential medicines will preferentially treated at drug price negotiation
Pharmaceutical companies which manufacture drugs that are essential for the national policies, but are in a difficult situation due to poor playability, are expected to be preferentially treated, like at drug price negotiations, by the government.
The Ministry of Food and Drug Safety(MFDS) annou...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
